These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6075274)
1. [Organization and economy in drug research]. Hermann E Nord Med; 1967 Nov; 78(47):1543-6. PubMed ID: 6075274 [No Abstract] [Full Text] [Related]
2. [Pharmacological research in drug industry]. Jacobsen E Nord Med; 1967 Nov; 78(47):1533-5. PubMed ID: 6075271 [No Abstract] [Full Text] [Related]
3. [Is clinical research in Denmark directed by drug industry?]. Jacobsen IA Ugeskr Laeger; 2004 Jun; 166(24):2367-8. PubMed ID: 15281581 [No Abstract] [Full Text] [Related]
4. Rights to life: are scientists wrong to patent genes? Gladwell M New Yorker; 1995 Nov; 71(36):120-4. PubMed ID: 11654950 [No Abstract] [Full Text] [Related]
5. [Clinical drug research in Denmark--as effective, harmless and cheap as possible]. Højgaard L Ugeskr Laeger; 1994 Feb; 156(6):784-6. PubMed ID: 8016979 [No Abstract] [Full Text] [Related]
6. [Health research--industry's point of view]. Dejgaard A; Diderichsen B Ugeskr Laeger; 2003 Jan; 165(4):319-20. PubMed ID: 12599791 [No Abstract] [Full Text] [Related]
7. [Tendencies and outlook in drug research and development]. Nowotny OH Fortschr Med; 1978 May; 96(18):939-40, 951. PubMed ID: 648996 [No Abstract] [Full Text] [Related]
8. [Does the public sector have an independent research role in the development of drugs?]. Poulsen HE; Grønlykke TB Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828 [TBL] [Abstract][Full Text] [Related]
9. [The roles and responsibilities of the pharmaceutical industry]. Dejgaard A; Thomsen MK Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829 [TBL] [Abstract][Full Text] [Related]
10. [FTF's opinion. OECD (Organization for Economic Cooperation and Development) points out that economy does not solve the crisis]. Sygeplejersken; 1983 Feb; 83(5):7. PubMed ID: 6551061 [No Abstract] [Full Text] [Related]
11. FDA issues concerning conflicts of interest. Kurt TL IRB; 1990; 12(5):6-9. PubMed ID: 11654003 [No Abstract] [Full Text] [Related]
15. Drug licensing: the case for royalties on off-patient drugs. Trout ME Hosp Formul; 1977 May; 12(5):342, 347. PubMed ID: 10318386 [No Abstract] [Full Text] [Related]
16. Patents, ethics and improving healthcare. Poste G; Roberts D; Gentry S Bull Med Ethics; 1997 Jan; No. 124():29-31. PubMed ID: 11655056 [No Abstract] [Full Text] [Related]
17. [Debate on clinical research without distortion of proportions]. Verland K Ugeskr Laeger; 2005 Apr; 167(14):1489. PubMed ID: 15887739 [No Abstract] [Full Text] [Related]
19. Xenotransplantation. Research in xenotransplantation will line drug industry's pockets. Fano A BMJ; 2000 Mar; 320(7238):869. PubMed ID: 10777314 [No Abstract] [Full Text] [Related]
20. The case for per patient payments. Lewis JP IRB; 1988; 10(5):9. PubMed ID: 11650075 [No Abstract] [Full Text] [Related] [Next] [New Search]